CitraFlow™ 46.7% SF for Vascular Access Device locking, from the Citra™ product line
CitraFlow™ 46.7% SF prefilled syringes are filled with an anticoagulant and antimicrobial 30% sodium citrate solution. CitraFlow™ 46.7% SF is a good alternative to heparin to lock Vascular Access Devices. It avoids the risks associated with systemic heparinization and is safe for use in patients with suspected or confirmed Heparin Induced Thrombocytopenia. CitraFlow™ 46.7% SF is also compatible with sterile fields.
Please consult our literature more information on the benefits of CitraFlow™ 46.7% SF.
Instructions for use (IFU) (pdf)